Evidence map›Paper›PMID 1633440›Full record

ReviewGene expression1992

Histone 3' ends: essential and regulatory functions.

W F Marzluff

Abstract readReview
In one paragraph

Review in Gene expression, 1992. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 65 papers.

0numbers the graph read from it
0cells of the map it votes in
65citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

65 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. The abbreviated pluripotent cell cycle.Journal of cellular physiology · 2013
    Review
  6. Review
  7. Article
  8. The histone gene activator HINFP is a nonredundant cyclin E/CDK2 effector during early embryonic cell cycles.Proceedings of the National Academy of Sciences of the United States of America · 2009
    Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Cotranscriptional processing of Drosophila histone mRNAs.Molecular and cellular biology · 2003
    Article
  15. Article
  16. A systematic approach to reconstructing transcription networks in Saccharomycescerevisiae.Proceedings of the National Academy of Sciences of the United States of America · 2002
    Article
  17. Article
  18. Article
  19. Article
  20. Article

5 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

1 author.

W F MarzluffProgram in Molecular Biology and Biotechnology, University of North Carolina, Chapel Hill 27599.

Funding

CONTROL OF HISTONE MRNA SYNTHESISR01GM029832 · NIGMS · UNIV OF NORTH CAROLINA CHAPEL HILL · PI DOMINSKI, ZBIGNIEW, MARZLUFF, WILLIAM F. · 1985 to 2022
$9.0M
NIGMS NIH HHS GM29832NIGMS NIH HHS R01 GM029832
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

AnimalsBase SequenceCell CycleHistonesMolecular Sequence DataRNA, MessengerRNA Processing, Post-TranscriptionalHistonesRNA, Messenger

Identifiers

PMID1633440
PMCPMC6057383

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.